4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-019565
EVP, Growth Markets Commercial sold 461 shares at $19.50 ($8,989)
- EVP, Growth Markets Commercial acquired 880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nazzi Gianfranco · EVP, Growth Markets Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-12 | Exercise or conversion : show line 1 in the form | +880 | 5,792.36 | D | ||
| 2018-03-12 | Sale : show line 2 in the form | −461 | $19.50 | $8,989 | 5,331.36 | D |
| Open-market sales · 461 sh · avg $19.50 · $8,989 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-03-12 | Exercise or conversion : show line 3 in the form Restricted Share Units | −880 | 883 | D |
Loading xslF345X03/doc4.xml…